NPS+ Type 2 Diabetes Mellitus (US)
本報告基於以美國的100名的醫生 (內分泌科醫生·一般醫生)為對象所進行的調查結果，彙整醫生對第二型糖尿病的領導品牌藥的利用趨勢及各種見解，以支援改善測試客戶忠誠度的NPS (淨推薦值) 指標。
Which brands are edging ahead of the rest in the brand satisfaction stakes?
The US market for Type 2 Diabetes Mellitus (T2DM) drugs has plenty of contenders - but which brands are the healthiest? What are the factors inspiring brand loyalty amongst US prescribers? And what can be done to convert detractors into promoters and, ultimately, improve market share?
FirstView's NPS+ Type 2 Diabetes Mellitus report assesses brand loyalty for 11 US T2DM treatments. Before planning your market access strategy, first find out not only how your brand is performing today, but also how it compares to its competitors in the loyalty stakes.
We surveyed 100 US Diabetologists chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.
We conducted the survey between September 5th and 12th, 2016.
NPS+ Type 2 Diabetes Mellitus (US) explores key issues affecting brand loyalty for T2DM drug manufacturers. You'll learn:
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
NPS measures overall brand satisfaction and loyalty by asking one simple question: "How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)-are used to classify respondents into 3 categories:
Detractors are those who answer 0 - 6. Passives are those who answer 7 - 8. Promoters are those who answer 9 - 10.
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.
Each NPS+ report examines doctors' relationships with the brands used to treat a major disease area-measuring brand loyalty and showing you how it affects your market share. NPS+ also examines "brand DNA", revealing in doctors' own words what brands mean to them.
Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.